Traders Purchase High Volume of Call Options on Imperva (IMPV)

Imperva Inc (NASDAQ:IMPV) saw some unusual options trading activity on Monday. Traders purchased 1,059 call options on the company. This represents an increase of approximately 1,758% compared to the typical volume of 57 call options.

Shares of Imperva (IMPV) remained flat at $$46.00 during trading on Wednesday. 491,125 shares of the company traded hands, compared to its average volume of 387,813. The firm has a market cap of $1,560.00, a price-to-earnings ratio of 68.66 and a beta of 1.79. Imperva has a one year low of $37.17 and a one year high of $52.40.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.13. The business had revenue of $91.10 million during the quarter, compared to analyst estimates of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. Imperva’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 earnings per share. analysts anticipate that Imperva will post -0.82 earnings per share for the current fiscal year.

A number of research analysts have recently issued reports on IMPV shares. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price for the company in a research note on Tuesday, October 24th. Morgan Stanley lifted their target price on shares of Imperva from $37.00 to $39.00 and gave the company an “underweight” rating in a research note on Friday, February 9th. Royal Bank of Canada reiterated a “buy” rating and issued a $49.00 target price on shares of Imperva in a research note on Wednesday, October 18th. BidaskClub upgraded shares of Imperva from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. Finally, Oppenheimer reiterated a “buy” rating and issued a $55.00 target price on shares of Imperva in a research note on Thursday, November 9th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $52.93.

Institutional investors have recently modified their holdings of the stock. New York State Common Retirement Fund increased its holdings in shares of Imperva by 5.3% in the second quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after purchasing an additional 1,793 shares in the last quarter. Prudential Financial Inc. increased its holdings in shares of Imperva by 80.7% in the third quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after purchasing an additional 24,190 shares in the last quarter. Wells Fargo & Company MN increased its holdings in shares of Imperva by 11.9% in the third quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after purchasing an additional 22,741 shares in the last quarter. American Century Companies Inc. acquired a new stake in shares of Imperva in the third quarter valued at approximately $6,832,000. Finally, Bank of New York Mellon Corp grew its holdings in Imperva by 10.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 150,752 shares of the software maker’s stock worth $6,542,000 after acquiring an additional 14,727 shares during the period. 93.61% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This piece was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/14/traders-purchase-high-volume-of-call-options-on-imperva-impv.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply